GLP-1 and Testosterone: What Men Need to Know

One of the first questions men ask about GLP-1 medications: "Will this tank my testosterone?" It's a fair concern. Obesity already suppresses testosterone, and any medical intervention that changes your body composition could theoretically shift hormone levels. The good news is that the evidence points in the opposite direction — GLP-1 therapy tends to improve testosterone, not lower it.

How Obesity Suppresses Testosterone

The relationship between body fat and testosterone in men is well-established and bidirectional:

• Aromatase conversion: Fat tissue — especially visceral abdominal fat — contains aromatase, the enzyme that converts testosterone to estradiol (estrogen). More fat = more conversion = lower free testosterone.
• SHBG reduction: Obesity lowers sex hormone-binding globulin, which paradoxically increases testosterone clearance and can lower total testosterone.
• Hypothalamic suppression: Excess fat and elevated estrogen suppress the hypothalamic-pituitary-gonadal axis, reducing the signal to produce testosterone.
• Insulin resistance: Hyperinsulinemia associated with obesity independently suppresses Leydig cell testosterone production.

This creates a metabolic trap: low testosterone makes it harder to build muscle and easier to gain fat, which further lowers testosterone. GLP-1 therapy attacks this cycle at the weight-loss entry point.

What the Research Shows

Clinical evidence consistently shows that significant weight loss improves testosterone levels in obese men:

• A meta-analysis of weight-loss studies found that losing 10–15% of body weight increased total testosterone by an average of 2.9 nmol/L (approximately 84 ng/dL).
• The STEP 1 trial subgroup analysis showed testosterone increases in male participants correlating with degree of weight loss.
• Men with obesity-related hypogonadism (low T due to weight) showed the most dramatic improvements — some moving from clinically low into normal range with weight loss alone.

GLP-1 and TRT: Can You Do Both?

Yes — many men use GLP-1 medications alongside testosterone replacement therapy. There are no direct pharmacological interactions between injectable GLP-1 agonists and testosterone. However, coordination matters:

• Body composition monitoring: Both GLP-1s and TRT affect muscle-to-fat ratio. Tracking lean mass helps your provider optimize both treatments.
• Hematocrit monitoring: TRT can increase red blood cell production. Ensure your provider monitors this regardless of GLP-1 use.
• Reassessment: As you lose weight on GLP-1 therapy, your testosterone may improve enough to reduce or discontinue TRT. Periodic testosterone testing guides this decision.

The Bottom Line for Men

GLP-1 medications don't lower testosterone — the weight loss they produce typically raises it. For men whose low T is driven by excess body fat, GLP-1 therapy may address both problems simultaneously. The catch is that muscle preservation through resistance training and adequate protein is essential — losing lean mass alongside fat would blunt the hormonal benefit.